Global Japanese Encephalitis Virus Vaccine Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing incidence of Japanese encephalitis in developing countries and growing awareness about the disease among people. Inactivated vaccine segment accounted for the largest share of the global market in 2018, followed by live attenuated vaccine segment. Public sector dominated the global market in 2018, while private sector is expected to grow at a higher CAGR during the forecast period due to increasing demand for vaccines from individuals and organizations across various regions globally. North America was estimated as one of the leading markets for Japanese encephalitis virus vaccine in 2018, followed by Europe and Asia Pacific respectively. Global Japanese Encephalitis Virus Vaccine Market By Type (Inactivated Vaccine, Live Attenuated Vaccine), By Application (Public, Private) And By Region (North America, Latin America, Europe, Asia Pacific And Middle East & Africa), Forecast From 2021 To 2030.
Some Of The Growth Factors Of This Market:
- The Japanese Encephalitis Virus Vaccine market is driven by the increasing number of cases of Japanese Encephalitis in developing countries, such as India and China.
- Increasing awareness about the disease and its prevention methods among people in developing countries will drive the growth of this market.
- Increasing government funding for research on new vaccines will also fuel the growth of this market.
- The high cost associated with manufacturing vaccines will be a challenge for manufacturers.
Industry Growth Insights published a new data on “Japanese Encephalitis Virus Vaccine Market”. The research report is titled “Japanese Encephalitis Virus Vaccine Market research by Types (Inactivated Vaccine, Live Attenuated Vaccine), By Applications (Public, Private), By Players/Companies Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, Wuhan Institute”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Japanese Encephalitis Virus Vaccine Market Research Report
By Type
Inactivated Vaccine, Live Attenuated Vaccine
By Application
Public, Private
By Companies
Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, Wuhan Institute
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Japanese Encephalitis Virus Vaccine Market Report Segments:
The global Japanese Encephalitis Virus Vaccine market is segmented on the basis of:
Types
Inactivated Vaccine, Live Attenuated Vaccine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public, Private
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Research Foundation for Microbial Diseases of Osaka University
- Valneva Austria GmbH
- Chengdu Institute
- Liaoning Dacheng
- Wuhan Institute
Highlights of The Japanese Encephalitis Virus Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Inactivated Vaccine
- Live Attenuated Vaccine
- By Application:
- Public
- Private
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Japanese Encephalitis Virus Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Japanese Encephalitis Virus Vaccine is a vaccine that helps protect people from getting Japanese Encephalitis. It is made from the virus itself, so it can help prevent infection.
Some of the key players operating in the japanese encephalitis virus vaccine market are Research Foundation for Microbial Diseases of Osaka University, Valneva Austria GmbH, Chengdu Institute, Liaoning Dacheng, Wuhan Institute.
The japanese encephalitis virus vaccine market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Japanese Encephalitis Virus Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Japanese Encephalitis Virus Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Japanese Encephalitis Virus Vaccine Market - Supply Chain
4.5. Global Japanese Encephalitis Virus Vaccine Market Forecast
4.5.1. Japanese Encephalitis Virus Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Japanese Encephalitis Virus Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Japanese Encephalitis Virus Vaccine Market Absolute $ Opportunity
5. Global Japanese Encephalitis Virus Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
5.3.1. Inactivated Vaccine
5.3.2. Live Attenuated Vaccine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Japanese Encephalitis Virus Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
6.3.1. Public
6.3.2. Private
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Japanese Encephalitis Virus Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Japanese Encephalitis Virus Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Japanese Encephalitis Virus Vaccine Demand Share Forecast, 2019-2026
9. North America Japanese Encephalitis Virus Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
9.4.1. Public
9.4.2. Private
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
9.7.1. Inactivated Vaccine
9.7.2. Live Attenuated Vaccine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Japanese Encephalitis Virus Vaccine Demand Share Forecast, 2019-2026
10. Latin America Japanese Encephalitis Virus Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
10.4.1. Public
10.4.2. Private
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
10.7.1. Inactivated Vaccine
10.7.2. Live Attenuated Vaccine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Japanese Encephalitis Virus Vaccine Demand Share Forecast, 2019-2026
11. Europe Japanese Encephalitis Virus Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
11.4.1. Public
11.4.2. Private
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
11.7.1. Inactivated Vaccine
11.7.2. Live Attenuated Vaccine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Japanese Encephalitis Virus Vaccine Demand Share, 2019-2026
12. Asia Pacific Japanese Encephalitis Virus Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
12.4.1. Public
12.4.2. Private
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
12.7.1. Inactivated Vaccine
12.7.2. Live Attenuated Vaccine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Japanese Encephalitis Virus Vaccine Demand Share, 2019-2026
13. Middle East & Africa Japanese Encephalitis Virus Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Application
13.4.1. Public
13.4.2. Private
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Japanese Encephalitis Virus Vaccine Market Size and Volume Forecast by Type
13.7.1. Inactivated Vaccine
13.7.2. Live Attenuated Vaccine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Japanese Encephalitis Virus Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Japanese Encephalitis Virus Vaccine Market: Market Share Analysis
14.2. Japanese Encephalitis Virus Vaccine Distributors and Customers
14.3. Japanese Encephalitis Virus Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Research Foundation for Microbial Diseases of Osaka University
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Valneva Austria GmbH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Chengdu Institute
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Liaoning Dacheng
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wuhan Institute
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook